Faye Su
Impact in
-
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
-
- Advanced Breast Cancer Therapies
Papers in
-
- Advanced Breast Cancer Therapies 13
- Oncology 10
- Lung Cancer Research Studies 6
- Cancer Treatment and Pharmacology 2
- Cancer-related Molecular Pathways 2
- Co-authors
- Naveen Babbar (7 shared papers)Sara A. Hurvitz (5 shared papers)Tong Luo (3 shared papers)Raul Ayala (4 shared papers)Alex Gaither (3 shared papers)Emmanuelle DiTomaso (4 shared papers)Dennis J. Slamon (5 shared papers)Neil A. O’Brien (4 shared papers)
- Journals
- Cancer Research (9 papers)Annals of Oncology (2 papers)Veterinary Sciences (1 paper)Breast Cancer Research (1 paper)Archives of cardiovascular diseases (1 paper)
- Partner nations
- United StatesSpainBelgium
In The Last Decade
Faye Su
14 papers receiving 168 citations
Peers
Comparison fields: 5 of 30
- Oncology 120
- Pulmonary and Respiratory Medicine 133
- Cancer Research 54
- Genetics 30
- Molecular Biology 46
Countries citing papers authored by Faye Su
This map shows the geographic impact of Faye Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faye Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faye Su more than expected).
Fields of papers citing papers by Faye Su
This network shows the impact of papers produced by Faye Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faye Su. The network helps show where Faye Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Faye Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 87 | |
| 2 | 2023 | 43 | |
| 3 | 2025 | 10 | |
| 4 | 2020 | 7 | |
| 5 | 2022 | 6 | |
| 6 | 2017 | 4 | |
| 7 | 2022 | 3 | |
| 8 | 2018 | 3 | |
| 9 | 2018 | 2 | |
| 10 | 2021 | 2 | |
| 11 | 2019 | 1 | |
| 12 | 2018 | 1 | |
| 13 | 2019 | 1 | |
| 14 | 2019 | 1 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 |
About Faye Su
Faye Su is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Epidemiology and Infectious Diseases, having authored 16 papers that have together received 171 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (13 papers), Lung Cancer Research Studies (6 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Treatment and Pharmacology (2 papers), Cancer-related Molecular Pathways (2 papers), Inflammatory Bowel Disease (1 paper), Breast Cancer Treatment Studies (1 paper) and Clostridium difficile and Clostridium perfringens research (1 paper). The work is most often cited by research in Oncology (120 citations), Pulmonary and Respiratory Medicine (133 citations), Cancer Research (54 citations), Genetics (30 citations) and Molecular Biology (46 citations). Faye Su has collaborated with scholars based in United States, Spain and Belgium. Frequent co-authors include Naveen Babbar, Sara A. Hurvitz, Tong Luo, Raul Ayala, Alex Gaither, Emmanuelle DiTomaso, Dennis J. Slamon, Neil A. O’Brien, Kristine Rose and Dylan Conklin. Their work appears in journals such as Cancer Research, Annals of Oncology, Veterinary Sciences, Breast Cancer Research and Archives of cardiovascular diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.